Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human light chain 3/
MAP1LC3B
, an autophagosomal ortholog of yeast Atg8, is conjugated to phospholipid (PL) via ubiquitylation-like reactions mediated by human Atg7 and Atg3. Since human Atg4B was found to cleave the carboxyl terminus of
MAP1LC3B
in vitro, we hypothesized that this exposes its carboxyl-terminal Gly(120). It was recently reported, however, that when Myc-
MAP1LC3B
-His is expressed in HEK293 cells, its carboxyl terminus is not cleaved. (Tanida, I., Sou, Y.-s., Ezaki, J., Minematsu-Ikeguchi, N., Ueno, T., and Kominami, E. (2004) J. Biol. Chem. 279, 36268-36276). To clarify this contradiction, we sought to determine whether the carboxyl terminus of
MAP1LC3B
is cleaved to expose Gly(120) for further ubiquitylation-like reactions. When
MAP1LC3B
-3xFLAG and Myc-
MAP1LC3B
-His were expressed in HEK293 cells, their carboxyl termini were cleaved, whereas there was little cleavage of mutant proteins
MAP1LC3B
(G120A)-3xFLAG and Myc-
MAP1LC3B
(G120A)-His, containing Ala in place of Gly(120). An in vitro assay showed that Gly(120) is essential for carboxyl-terminal cleavage by human Atg4B as well as for formation of the intermediates Atg7-
MAP1LC3B
(
ubiquitin-activating enzyme
-substrate) and Atg3-
MAP1LC3B
(ubiquitin carrier protein-substrate). Recombinant
MAP1LC3B
-PL was fractionated into the 100,000 x g pellet in a manner similar to that shown for endogenous
MAP1LC3B
-PL. RNA interference of
MAP1LC3B
mRNA resulted in a decrease in both endogenous
MAP1LC3B
-PL and
MAP1LC3B
. These results indicate that the carboxyl terminus of
MAP1LC3B
is cleaved to expose Gly(120) for further ubiquitylation-like reactions.
...
PMID:Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. 1535 58
Although genome-wide association studies have identified the gene
RNF186
encoding an E3
ubiquitin-protein ligase
as conferring susceptibility to ulcerative colitis, the exact function of this protein remains unclear. In the present study, we demonstrate an important role for RNF186 in macroautophagy/autophagy activation in colonic epithelial cells and intestinal homeostasis. Mechanistically, RNF186 acts as an E3
ubiquitin-protein ligase
for EPHB2 and regulates the ubiquitination of EPHB2. Upon stimulation by ligand EFNB1 (ephrin B1), EPHB2 is ubiquitinated by RNF186 at Lys892, and further recruits
MAP1LC3B
for autophagy. Compared to control mice,
rnf186
-/-
and
ephb2
-/-
mice have a more severe phenotype in the DSS-induced colitis model, which is due to a defect in autophagy in colon epithelial cells. More importantly, treatment with ephrin-B1-Fc recombinant protein effectively relieves DSS-induced mouse colitis, which suggests that ephrin-B1-Fc may be a potential therapy for human inflammatory bowel diseases.
...
PMID:RNF186 regulates EFNB1 (ephrin B1)-EPHB2-induced autophagy in the colonic epithelial cells for the maintenance of intestinal homeostasis. 3328 Apr 98